Company Analysis

AEON Biopharma, Inc. (AEON)

NYSE: AEON · Pharmaceutical Preparations · Irvine, CA · filing with the SEC since 2020
Grade4.4
◀ Past 5.7● Present 2.0▶ Future 5.7
6 est.

Who runs AEON Biopharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Palmisano Robert J
CEO. First filing Feb 2021, latest Jun 22, 2026, 0 filings in all.
Officers reporting now
7
of 10 people with a filing in the last fifteen months
Directors reporting now
3
19 people on the record since 2021
Officerssales are open-market, Nov 10, 2025 to Nov 10, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Palmisano Robert JCEOFeb 2021Jun 22, 2026none
Forth MarcCHIEF EXECTUIVE OFFICERJul 2023Jun 22, 2026none
Bencich JohnCHIEF FINANCIAL OFFICERApr 2026Apr 3, 2026none
Oh ChadCHIEF MEDICAL OFFICERJul 2023Mar 11, 2026none
Sy JenniferPRINCIPAL ACCOUNTING OFFICERMay 2024Mar 5, 2026none
Wilson Alexander BlairCLO, CSO, and Corp SecretaryJul 2023Mar 5, 2026none
Bancroft Robert E.PRESIDENT & CEOMay 2025Feb 19, 2026none
Directorssales are open-market, Nov 10, 2025 to Nov 10, 2026
NameRoleFirst filingLatest filingSales, 12 months
Carter Eric GdirectorJul 2023Jun 22, 2026none
Fischer JostdirectorJul 2023Jun 22, 2026none
Thunen Shelley BdirectorJul 2023Jun 22, 2026none
Owners of more than 10% of a classsales are open-market, Nov 10, 2025 to Nov 10, 2026
NameRoleFirst filingLatest filingSales, 12 months
Daewoong Co., Ltd10% ownerJul 2023Nov 10, 2026none
Lynch Timothy P10% ownerAug 2026Aug 21, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AEON · research, not advice